naltrexone has been researched along with Memory Disorders in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Barrientos, RM; Clements, MA; Duran-Malle, JC; Harris, KM; Kwilasz, AJ; Larson, TA; Litwiler, ST; Maier, SF; Mitten, EH; Rice, KC; Schrama, AEW; Todd, LS; Van Dam, AM; Wang, X; Watkins, LR | 1 |
Dehpour, AR; Ebadian, S; Ghiassy, B; Javadi-Paydar, M; Norouzi, A; Rahimi, N | 1 |
Brewer, KL; Meggs, WJ; Tran, T | 1 |
Carey, AN; Dunton, O; Lyons, AM; McLaughlin, JP; Shay, CF | 1 |
Kjome, KL; Kramer, LA; Liu, S; Ma, L; Moeller, FG; Narayana, PA; Rathnayaka, N; Schmitz, JM; Steinberg, JL | 1 |
Ownegh, V; Rezvanfard, M; Zarrindast, MR | 1 |
Hiramatsu, M; Hoshino, T | 1 |
Rashidy-Pour, A; Sajadi, AA; Samaei, SA | 1 |
Itoh, J; Kameyama, T; Kobayashi, T; Shinkai, N; Ukai, M | 1 |
Hiramatsu, M; Inoue, K | 1 |
Katoh, T; Mamiya, T; Ukai, M | 1 |
Lipschitz, A | 1 |
Weiss, BL | 1 |
3 trial(s) available for naltrexone and Memory Disorders
Article | Year |
---|---|
Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats.
Topics: Animals; Cholestasis; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Guanidines; Ligation; Male; Maze Learning; Memory Disorders; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Space Perception; Time Factors | 2013 |
Working memory fMRI activation in cocaine-dependent subjects: association with treatment response.
Topics: Adult; Amphetamine; Analysis of Variance; Benzhydryl Compounds; Brain; Brain Mapping; Carbidopa; Central Nervous System Stimulants; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Dopamine Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mathematics; Memory Disorders; Memory, Short-Term; Middle Aged; Modafinil; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Oxygen | 2010 |
Failure of nalmefene and estrogen to improve memory in Alzheimer's disease.
Topics: Alzheimer Disease; Clinical Trials as Topic; Estradiol; Female; Humans; Memory; Memory Disorders; Naltrexone | 1987 |
10 other study(ies) available for naltrexone and Memory Disorders
Article | Year |
---|---|
Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone.
Topics: Animals; Behavior, Animal; Cells, Cultured; Conditioning, Classical; Encephalomyelitis, Autoimmune, Experimental; Fear; Hippocampus; Inflammation; Male; Memory Disorders; Mice; Microglia; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2021 |
Chronic Treatment with Naltrexone Prevents Memory Retention Deficits in Rats Poisoned with the Sarin Analog Diisopropylfluorophosphate (DFP) and Treated with Atropine and Pralidoxime.
Topics: Animals; Atropine; Female; Isoflurophate; Memory Disorders; Naltrexone; Pralidoxime Compounds; Rats; Rats, Long-Evans | 2015 |
Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Behavior, Animal; Enkephalins; Gene Expression Regulation; Immobility Response, Tonic; Learning Disabilities; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Naltrexone; Narcotic Antagonists; Protein Precursors; Receptors, Opioid, kappa; Recognition, Psychology; Stress, Psychological; Swimming; Time Factors | 2009 |
Systemic opioid receptor antagonism blocks swim stress-induced retention impairment independently from CA1 and BLA opioidergic pathways.
Topics: Amygdala; Animals; Avoidance Learning; Behavior, Animal; CA1 Region, Hippocampal; Male; Memory Disorders; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Retention, Psychology; Stress, Psychological; Swimming | 2011 |
Improvement of memory impairment by (+)- and (-)-pentazocine via sigma, but not kappa opioid receptors.
Topics: Acetic Acid; Analgesics, Opioid; Analysis of Variance; Animals; Anisoles; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Isomerism; Male; Maze Learning; Memory Disorders; Mice; Naltrexone; Narcotic Antagonists; Pain Measurement; Pentazocine; Propylamines; Receptors, Opioid, kappa; Receptors, sigma; Scopolamine | 2005 |
Blocking effects of intra-hippocampal naltrexone microinjections on glucocorticoid-induced impairment of spatial memory retrieval in rats.
Topics: Animals; Behavior, Animal; Corticosterone; Dose-Response Relationship, Drug; Hippocampus; Male; Maze Learning; Memory Disorders; Microinjections; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Reaction Time; Spatial Behavior | 2007 |
Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice.
Topics: Analgesics, Opioid; Animals; Dynorphins; Injections, Intraventricular; Learning; Learning Disabilities; Male; Memory; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Naltrexone; Narcotic Antagonists; Peptide Fragments; Pirenzepine; Receptors, Opioid, kappa; Scopolamine | 1997 |
Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory.
Topics: Analgesics, Opioid; Animals; Avoidance Learning; Disease Models, Animal; Dizocilpine Maleate; Learning Disabilities; Male; Maze Learning; Memory Disorders; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Nociceptin; Opioid Peptides; Psychomotor Performance; Rats; Scopolamine | 2000 |
Endomorphin-1 improves scopolamine-induced impairment of short-term memory via mu1-opioid receptor in mice.
Topics: Analgesics, Opioid; Animals; Brain; Dose-Response Relationship, Drug; Drug Interactions; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Mice; Muscarinic Antagonists; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Oligopeptides; Receptors, Opioid, mu; Scopolamine | 2001 |
Naltrexone challenge for hypercortisolemic pseudodementia.
Topics: Dementia; Diagnosis, Differential; Hippocampus; Humans; Hydrocortisone; Memory Disorders; Naltrexone | 1991 |